{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:29:39Z","timestamp":1791289779121,"version":"4.3.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T00:00:00Z","timestamp":1458777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T00:00:00Z","timestamp":1458777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Council for Chemical Sciences of the Netherlands Organization for Scientific Research","award":["700.54.304"],"award-info":[{"award-number":["700.54.304"]}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["233229"],"award-info":[{"award-number":["233229"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"European Community's Seventh Framework Programmes","doi-asserted-by":"publisher","award":["283570 (BioStruct\u2010X), 602699 (FP7\/DIREKT)"],"award-info":[{"award-number":["283570 (BioStruct\u2010X), 602699 (FP7\/DIREKT)"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI068730"],"award-info":[{"award-number":["AI068730"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI030040"],"award-info":[{"award-number":["AI030040"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM0099111"],"award-info":[{"award-number":["GM0099111"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GK112303\u201003"],"award-info":[{"award-number":["GK112303\u201003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1423304"],"award-info":[{"award-number":["1423304"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30AR048335"],"award-info":[{"award-number":["P30AR048335"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Dutch Kidney Foundation","doi-asserted-by":"publisher","award":["13OI116"],"award-info":[{"award-number":["13OI116"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Dutch Kidney Foundation","doi-asserted-by":"publisher","award":["KFB 11.007"],"award-info":[{"award-number":["KFB 11.007"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Dutch Kidney Foundation","doi-asserted-by":"publisher","award":["IP 10.22"],"award-info":[{"award-number":["IP 10.22"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERA\u2010EDTA","award":["ERA LTF 203\u20102014"],"award-info":[{"award-number":["ERA LTF 203\u20102014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO J"],"published-print":{"date-parts":[[2016,5,17]]},"DOI":"10.15252\/embj.201593673","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T21:48:06Z","timestamp":1458856086000},"page":"1133-1149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Regulators of complement activity mediate inhibitory mechanisms through a common C3b\u2010binding mode"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7818-1804","authenticated-orcid":false,"given":"Federico","family":"Forneris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6140-0233","authenticated-orcid":false,"given":"Daniel","family":"Ricklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoer","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Sfyroera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolia","family":"Tzekou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Volokhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke CM","family":"Granneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hauhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Bertram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Kathryn","family":"Liszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Lambris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7782-2585","authenticated-orcid":false,"given":"Piet","family":"Gros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,24]]},"reference":[{"key":"BFEMBJ201593673_CR1","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.4049\/jimmunol.147.9.3005","volume":"147","author":"EM Adams","year":"1991","unstructured":"Adams EM, Brown MC, Nunge M, Krych M, Atkinson JP (1991) Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity. J Immunol 147: 3005\u20133011","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse\u2010Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH (2010) PHENIX: a comprehensive Python\u2010based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213\u2013221","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"BFEMBJ201593673_CR3","first-page":"331","volume":"44","author":"M Ahmad","year":"2007","unstructured":"Ahmad M, Pyaram K, Mullick J, Sahu A (2007) Viral complement regulators: the expert mimicking swindlers. Indian J Biochem Biophys 44: 331\u2013343","journal-title":"Indian J Biochem Biophys"},{"key":"BFEMBJ201593673_CR4","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.4049\/jimmunol.1001617","volume":"185","author":"M Ahmad","year":"2010","unstructured":"Ahmad M, Raut S, Pyaram K, Kamble A, Mullick J, Sahu A (2010) Domain swapping reveals complement control protein modules critical for imparting cofactor and decay\u2010accelerating activities in vaccinia virus complement control protein. J Immunol 185: 6128\u20136137","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR5","doi-asserted-by":"crossref","first-page":"19642","DOI":"10.1074\/jbc.M112.361121","volume":"287","author":"AE Aleshin","year":"2012","unstructured":"Aleshin AE, DiScipio RG, Stec B, Liddington RC (2012) Crystal structure of C5b\u20106 suggests structural basis for priming assembly of the membrane attack complex. J Biol Chem 287: 19642\u201319652","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR500","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1073\/pnas.181342398","volume":"98","author":"NA Baker","year":"2001","unstructured":"Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA (2001) Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA 98: 10037\u201310041","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201593673_CR501","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1107\/S0907444910048675","volume":"67","author":"TG Battye","year":"2011","unstructured":"Battye TG, Kontogiannis L, Johnson O, Powell HR, Leslie AG (2011) iMOSFLM: a new graphical interface for diffraction\u2010image processing with MOSFLM. Acta Crystallogr D Biol Crystallogr 67: 271\u2013281","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"BFEMBJ201593673_CR6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2567.2003.01579.x","volume":"108","author":"DJ Birmingham","year":"2003","unstructured":"Birmingham DJ, Chen W, Liang G, Schmitt HC, Gavit K, Nagaraja HN (2003) A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b. Immunology 108: 531\u2013538","journal-title":"Immunology"},{"key":"BFEMBJ201593673_CR7","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1093\/emboj\/18.19.5166","volume":"18","author":"B Bouma","year":"1999","unstructured":"Bouma B, de Groot PG, van den Elsen JM, Ravelli RB, Schouten A, Simmelink MJ, Derksen RH, Kroon J, Gros P (1999) Adhesion mechanism of human beta(2)\u2010glycoprotein I to phospholipids based on its crystal structure. EMBO J 18: 5166\u20135174","journal-title":"EMBO J"},{"key":"BFEMBJ201593673_CR8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","volume":"108","author":"J Caprioli","year":"2006","unstructured":"Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P, Mele C, Bresin E, Cassis L, Gamba S, Porrati F, Bucchioni S, Monteferrante G, Fang CJ, Liszewski MK, Kavanagh D, Atkinson JP, Remuzzi G (2006) Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108: 1267\u20131279","journal-title":"Blood"},{"key":"BFEMBJ201593673_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen VB, Arendall WB 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC (2010) MolProbity: all\u2010atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66: 12\u201321","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"BFEMBJ201593673_CR10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.gene.2005.05.008","volume":"355","author":"E Ciulla","year":"2005","unstructured":"Ciulla E, Emery A, Konz D, Krushkal J (2005) Evolutionary history of orthopoxvirus proteins similar to human complement regulators. Gene 355: 40\u201347","journal-title":"Gene"},{"key":"BFEMBJ201593673_CR11","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.4049\/jimmunol.1201751","volume":"190","author":"SJ Clark","year":"2013","unstructured":"Clark SJ, Ridge LA, Herbert AP, Hakobyan S, Mulloy B, Lennon R, Wurzner R, Morgan BP, Uhrin D, Bishop PN, Day AJ (2013) Tissue\u2010specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan\u2010binding regions. J Immunol 190: 2049\u20132057","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","volume":"50","author":"Collaborative Computational Project, Number 4","year":"1994","unstructured":"Collaborative Computational Project, Number 4 (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50: 760\u2013763","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"BFEMBJ201593673_CR13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-0030-1262885","volume":"36","author":"MA Dragon\u2010Durey","year":"2010","unstructured":"Dragon\u2010Durey MA, Blanc C, Garnier A, Hofer J, Sethi SK, Zimmerhackl LB (2010) Anti\u2010factor H autoantibody\u2010associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS. Semin Thromb Hemost 36: 633\u2013640","journal-title":"Semin Thromb Hemost"},{"key":"BFEMBJ201593673_CR14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00281-005-0003-2","volume":"27","author":"MA Dragon\u2010Durey","year":"2005","unstructured":"Dragon\u2010Durey MA, Fremeaux\u2010Bacchi V (2005) Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. Springer Semin Immunopathol 27: 359\u2013374","journal-title":"Springer Semin Immunopathol"},{"key":"BFEMBJ201593673_CR15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallographica Section\u00a0D 66: 486\u2013501","journal-title":"Acta Crystallographica Section\u00a0D"},{"key":"BFEMBJ201593673_CR16","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.1195821","volume":"330","author":"F Forneris","year":"2010","unstructured":"Forneris F, Ricklin D, Wu J, Tzekou A, Wallace RS, Lambris JD, Gros P (2010) Structures of C3b in complex with factors B and D give insight into complement convertase formation. Science 330: 1816\u20131820","journal-title":"Science"},{"key":"BFEMBJ201593673_CR17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.sbi.2012.04.001","volume":"22","author":"F Forneris","year":"2012","unstructured":"Forneris F, Wu J, Gros P (2012) The modular serine proteases of the complement cascade. Curr Opin Struct Biol 22: 333\u2013341","journal-title":"Curr Opin Struct Biol"},{"key":"BFEMBJ201593673_CR18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jmb.2006.06.009","volume":"361","author":"F Fredslund","year":"2006","unstructured":"Fredslund F, Jenner L, Husted LB, Nyborg J, Andersen GR, Sottrup\u2010Jensen L (2006) The structure of bovine complement component 3 reveals the basis for thioester function. J Mol Biol 361: 115\u2013127","journal-title":"J Mol Biol"},{"key":"BFEMBJ201593673_CR19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ni.1625","volume":"9","author":"F Fredslund","year":"2008","unstructured":"Fredslund F, Laursen NS, Roversi P, Jenner L, Oliveira CL, Pedersen JS, Nunn MA, Lea SM, Discipio R, Sottrup\u2010Jensen L, Andersen GR (2008) Structure of and influence of a tick complement inhibitor on human complement component 5. Nat Immunol 9: 753\u2013760","journal-title":"Nat Immunol"},{"key":"BFEMBJ201593673_CR20","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","volume":"112","author":"V Fremeaux\u2010Bacchi","year":"2008","unstructured":"Fremeaux\u2010Bacchi V, Miller EC, Liszewski MK, Strain L, Blouin J, Brown AL, Moghal N, Kaplan BS, Weiss RA, Lhotta K, Kapur G, Mattoo T, Nivet H, Wong W, Gie S, Hurault de Ligny B, Fischbach M, Gupta R, Hauhart R, Meunier V et\u00a0al (2008) Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112: 4948\u20134952","journal-title":"Blood"},{"key":"BFEMBJ201593673_CR21","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1681\/ASN.2005101051","volume":"17","author":"V Fremeaux\u2010Bacchi","year":"2006","unstructured":"Fremeaux\u2010Bacchi V, Moulton EA, Kavanagh D, Dragon\u2010Durey MA, Blouin J, Caudy A, Arzouk N, Cleper R, Francois M, Guest G, Pourrat J, Seligman R, Fridman WH, Loirat C, Atkinson JP (2006) Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 17: 2017\u20132025","journal-title":"J Am Soc Nephrol"},{"key":"BFEMBJ201593673_CR22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jmb.2007.09.085","volume":"375","author":"PB Furtado","year":"2008","unstructured":"Furtado PB, Huang CY, Ihyembe D, Hammond RA, Marsh HC, Perkins SJ (2008) The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands. J Mol Biol 375: 102\u2013118","journal-title":"J Mol Biol"},{"key":"BFEMBJ201593673_CR23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jmb.2010.07.029","volume":"402","author":"BL Garcia","year":"2010","unstructured":"Garcia BL, Ramyar KX, Tzekou A, Ricklin D, McWhorter WJ, Lambris JD, Geisbrecht BV (2010) Molecular Basis for Complement Recognition and Inhibition Determined by Crystallographic Studies of the Staphylococcal Complement Inhibitor (SCIN) Bound to C3c and C3b. J Mol Biol 402: 17\u201329","journal-title":"J Mol Biol"},{"key":"BFEMBJ201593673_CR24","doi-asserted-by":"crossref","first-page":"12794","DOI":"10.1073\/pnas.1506449112","volume":"112","author":"AK Gautam","year":"2015","unstructured":"Gautam AK, Panse Y, Ghosh P, Reza MJ, Mullick J, Sahu A (2015) Mutational analysis of Kaposica reveals that bridging of MG2 and CUB domains of target protein is crucial for the cofactor activity of RCA proteins. Proc Natl Acad Sci USA 112: 12794\u201312799","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201593673_CR25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4049\/jimmunol.155.1.348","volume":"155","author":"DL Gordon","year":"1995","unstructured":"Gordon DL, Kaufman RM, Blackmore TK, Kwong J, Lublin DM (1995) Identification of complement regulatory domains in human factor H. J Immunol 155: 348\u2013356","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR26","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1182\/blood-2011-02-339564","volume":"118","author":"K Gropp","year":"2011","unstructured":"Gropp K, Weber N, Reuter M, Micklisch S, Kopka I, Hallstrom T, Skerka C (2011) beta(2)\u2010glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator. Blood 118: 2774\u20132783","journal-title":"Blood"},{"key":"BFEMBJ201593673_CR27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.celrep.2012.02.003","volume":"1","author":"MA Hadders","year":"2012","unstructured":"Hadders MA, Bubeck D, Roversi P, Hakobyan S, Forneris F, Morgan BP, Pangburn MK, Llorca O, Lea SM, Gros P (2012) Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. Cell Rep 1: 200\u2013207","journal-title":"Cell Rep"},{"key":"BFEMBJ201593673_CR502","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1074\/jbc.M410179200","volume":"280","author":"CL Harris","year":"2005","unstructured":"Harris CL, Abbott RJ, Smith RA, Morgan BP, Lea SM (2005) Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55). J Biol Chem 280: 2569\u20132578","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4049\/jimmunol.178.1.352","volume":"178","author":"CL Harris","year":"2007","unstructured":"Harris CL, Pettigrew DM, Lea SM, Morgan BP (2007) Decay\u2010accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay. J Immunol 178: 352\u2013359","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR29","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4049\/jimmunol.1300269","volume":"191","author":"M Hebecker","year":"2013","unstructured":"Hebecker M, Alba\u2010Dominguez M, Roumenina LT, Reuter S, Hyvarinen S, Dragon\u2010Durey MA, Jokiranta TS, Sanchez\u2010Corral P, Jozsi M (2013) An engineered construct combining complement regulatory and surface\u2010recognition domains represents a minimal\u2010size functional factor H. J Immunol 191: 912\u2013921","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR503","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.1019338108","volume":"108","author":"M Heurich","year":"2011","unstructured":"Heurich M, Martinez\u2010Barricarte R, Francis NJ, Roberts DL, Rodriguez de Cordoba S, Morgan BP, Harris CL (2011) Common polymorphisms in C3,\u00a0factor B, and factor H collaborate to determine systemic complement activity and disease risk. Proc Natl Acad Sci USA 108: 8761\u20138766","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201593673_CR30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0162-3109(99)00005-3","volume":"42","author":"DE Hourcade","year":"1999","unstructured":"Hourcade DE, Mitchell LM, Medof ME (1999) Decay acceleration of the complement alternative pathway C3 convertase. Immunopharmacology 42: 167\u2013173","journal-title":"Immunopharmacology"},{"key":"BFEMBJ201593673_CR31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature05172","volume":"444","author":"BJ Janssen","year":"2006","unstructured":"Janssen BJ, Christodoulidou A, McCarthy A, Lambris JD, Gros P (2006) Structure of C3b reveals conformational changes that underlie complement activity. Nature 444: 213\u2013216","journal-title":"Nature"},{"key":"BFEMBJ201593673_CR32","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/emboj.2009.184","volume":"28","author":"BJ Janssen","year":"2009","unstructured":"Janssen BJ, Gomes L, Koning RI, Svergun DI, Koster AJ, Fritzinger DC, Vogel CW, Gros P (2009) Insights into complement convertase formation based on the structure of the factor B\u2010cobra venom factor complex. EMBO J 28: 2469\u20132478","journal-title":"EMBO J"},{"key":"BFEMBJ201593673_CR33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature04005","volume":"437","author":"BJ Janssen","year":"2005","unstructured":"Janssen BJ, Huizinga EG, Raaijmakers HC, Roos A, Daha MR, Nilsson\u2010Ekdahl K, Nilsson B, Gros P (2005) Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437: 505\u2013511","journal-title":"Nature"},{"key":"BFEMBJ201593673_CR34","doi-asserted-by":"crossref","first-page":"27657","DOI":"10.1074\/jbc.M002903200","volume":"275","author":"TS Jokiranta","year":"2000","unstructured":"Jokiranta TS, Hellwage J, Koistinen V, Zipfel PF, Meri S (2000) Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J Biol Chem 275: 27657\u201327662","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch W (2010) Xds. Acta Crystallogr D Biol Crystallogr 66: 125\u2013132","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"BFEMBJ201593673_CR36","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1073\/pnas.1017087108","volume":"108","author":"T Kajander","year":"2011","unstructured":"Kajander T, Lehtinen MJ, Hyvarinen S, Bhattacharjee A, Leung E, Isenman DE, Meri S, Goldman A, Jokiranta TS (2011) Dual interaction of factor H with C3d and glycosaminoglycans in host\u2010nonhost discrimination by complement. Proc Natl Acad Sci USA 108: 2897\u20132902","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201593673_CR37","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1126\/science.1218231","volume":"336","author":"PA Karplus","year":"2012","unstructured":"Karplus PA, Diederichs K (2012) Linking crystallographic model and data quality. Science 336: 1030\u20131033","journal-title":"Science"},{"key":"BFEMBJ201593673_CR38","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1074\/jbc.M809106200","volume":"284","author":"KJ Katschke Jr","year":"2009","unstructured":"Katschke KJ Jr, Stawicki S, Yin J, Steffek M, Xi H, Sturgeon L, Hass PE, Loyet KM, Deforge L, Wu Y, van Lookeren Campagne M, Wiesmann C (2009) Structural and functional analysis of a C3b\u2010specific antibody that selectively inhibits the alternative pathway of complement. J Biol Chem 284: 10473\u201310479","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR39","doi-asserted-by":"crossref","first-page":"15425","DOI":"10.1073\/pnas.1208031109","volume":"109","author":"RT Kidmose","year":"2012","unstructured":"Kidmose RT, Laursen NS, Dobo J, Kjaer TR, Sirotkina S, Yatime L, Sottrup\u2010Jensen L, Thiel S, Gal P, Andersen GR (2012) Structural basis for activation of the complement system by component C4 cleavage. Proc Natl Acad Sci USA 109: 15425\u201315430","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201593673_CR40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1034\/j.1600-065X.2001.1800113.x","volume":"180","author":"MD Kirkitadze","year":"2001","unstructured":"Kirkitadze MD, Barlow PN (2001) Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol Rev 180: 146\u2013161","journal-title":"Immunol Rev"},{"key":"BFEMBJ201593673_CR41","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1021\/bi982453a","volume":"38","author":"MD Kirkitadze","year":"1999","unstructured":"Kirkitadze MD, Krych M, Uhrin D, Dryden DT, Smith BO, Cooper A, Wang X, Hauhart R, Atkinson JP, Barlow PN (1999) Independently melting modules and highly structured intermodular junctions within complement receptor type 1. Biochemistry 38: 7019\u20137031","journal-title":"Biochemistry"},{"key":"BFEMBJ201593673_CR42","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372: 774\u2013797","journal-title":"J Mol Biol"},{"key":"BFEMBJ201593673_CR43","doi-asserted-by":"crossref","first-page":"13273","DOI":"10.1016\/S0021-9258(17)36829-1","volume":"269","author":"M Krych","year":"1994","unstructured":"Krych M, Clemenza L, Howdeshell D, Hauhart R, Hourcade D, Atkinson JP (1994) Analysis of the functional domains of complement receptor type 1 (C3b\/C4b receptor; CD35) by substitution mutagenesis. J Biol Chem 269: 13273\u201313278","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR44","doi-asserted-by":"crossref","first-page":"8623","DOI":"10.1074\/jbc.273.15.8623","volume":"273","author":"M Krych","year":"1998","unstructured":"Krych M, Hauhart R, Atkinson JP (1998) Structure\u2010function analysis of the active sites of complement receptor type 1. J Biol Chem 273: 8623\u20138629","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR45","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1073\/pnas.88.10.4353","volume":"88","author":"M Krych","year":"1991","unstructured":"Krych M, Hourcade D, Atkinson JP (1991) Sites within the complement C3b\/C4b receptor important for the specificity of ligand binding. Proc Natl Acad Sci USA 88: 4353\u20134357","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201593673_CR46","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.4049\/jimmunol.175.7.4528","volume":"175","author":"M Krych\u2010Goldberg","year":"2005","unstructured":"Krych\u2010Goldberg M, Hauhart RE, Porzukowiak T, Atkinson JP (2005) Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors. J Immunol 175: 4528\u20134535","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR47","doi-asserted-by":"crossref","first-page":"31160","DOI":"10.1074\/jbc.274.44.31160","volume":"274","author":"M Krych\u2010Goldberg","year":"1999","unstructured":"Krych\u2010Goldberg M, Hauhart RE, Subramanian VB, Yurcisin BM 2nd, Crimmins DL, Hourcade DE, Atkinson JP (1999) Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases. J Biol Chem 274: 31160\u201331168","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR48","doi-asserted-by":"crossref","first-page":"18552","DOI":"10.1074\/jbc.M611650200","volume":"282","author":"L Kuttner\u2010Kondo","year":"2007","unstructured":"Kuttner\u2010Kondo L, Hourcade DE, Anderson VE, Muqim N, Mitchell L, Soares DC, Barlow PN, Medof ME (2007) Structure\u2010based mapping of DAF active site residues that accelerate the decay of C3 convertases. J Biol Chem 282: 18552\u201318562","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR49","doi-asserted-by":"crossref","first-page":"52386","DOI":"10.1074\/jbc.M304620200","volume":"278","author":"LA Kuttner\u2010Kondo","year":"2003","unstructured":"Kuttner\u2010Kondo LA, Dybvig MP, Mitchell LM, Muqim N, Atkinson JP, Medof ME, Hourcade DE (2003) A corresponding tyrosine residue in the C2\/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases. J Biol Chem 278: 52386\u201352391","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR50","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.4049\/jimmunol.167.4.2164","volume":"167","author":"LA Kuttner\u2010Kondo","year":"2001","unstructured":"Kuttner\u2010Kondo LA, Mitchell L, Hourcade DE, Medof ME (2001) Characterization of the active sites in decay\u2010accelerating factor. J Immunol 167: 2164\u20132171","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR51","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.4049\/jimmunol.156.12.4821","volume":"156","author":"JD Lambris","year":"1996","unstructured":"Lambris JD, Lao Z, Oglesby TJ, Atkinson JP, Hack CE, Becherer JD (1996) Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component. J Immunol 156: 4821\u20134832","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR54","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/joim.12338","volume":"277","author":"MK Liszewski","year":"2015","unstructured":"Liszewski MK, Atkinson JP (2015a) Complement regulators in human disease: lessons from modern genetics. J Intern Med 277: 294\u2013305","journal-title":"J Intern Med"},{"key":"BFEMBJ201593673_CR55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40246-015-0029-z","volume":"9","author":"MK Liszewski","year":"2015","unstructured":"Liszewski MK, Atkinson JP (2015b) Complement regulator CD46: genetic variants and disease associations. Hum Genomics 9: 7","journal-title":"Hum Genomics"},{"key":"BFEMBJ201593673_CR56","doi-asserted-by":"crossref","first-page":"37692","DOI":"10.1074\/jbc.M004650200","volume":"275","author":"MK Liszewski","year":"2000","unstructured":"Liszewski MK, Leung M, Cui W, Subramanian VB, Parkinson J, Barlow PN, Manchester M, Atkinson JP (2000) Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J Biol Chem 275: 37692\u201337701","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR57","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.4049\/jimmunol.161.7.3711","volume":"161","author":"MK Liszewski","year":"1998","unstructured":"Liszewski MK, Leung MK, Atkinson JP (1998) Membrane cofactor protein: importance of N\u2010 and O\u2010glycosylation for complement regulatory function. J Immunol 161: 3711\u20133718","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR58","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.4049\/jimmunol.176.6.3725","volume":"176","author":"MK Liszewski","year":"2006","unstructured":"Liszewski MK, Leung MK, Hauhart R, Buller RM, Bertram P, Wang X, Rosengard AM, Kotwal GJ, Atkinson JP (2006) Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J Immunol 176: 3725\u20133734","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR59","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.4049\/jimmunol.0901366","volume":"183","author":"MK Liszewski","year":"2009","unstructured":"Liszewski MK, Leung MK, Hauhart R, Fang CJ, Bertram P, Atkinson JP (2009) Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity. J Immunol 183: 3150\u20133159","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR60","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1073\/pnas.0307200101","volume":"101","author":"P Lukacik","year":"2004","unstructured":"Lukacik P, Roversi P, White J, Esser D, Smith GP, Billington J, Williams PA, Rudd PM, Wormald MR, Harvey DJ, Crispin MD, Radcliffe CM, Dwek RA, Evans DJ, Morgan BP, Smith RA, Lea SM (2004) Complement regulation at the molecular level: the structure of decay\u2010accelerating factor. Proc Natl Acad Sci USA 101: 1279\u20131284","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201593673_CR61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2105-5-69","volume":"5","author":"T Lutteke","year":"2004","unstructured":"Lutteke T, von der Lieth CW (2004) pdb\u2010care (PDB carbohydrate residue check): a program to support annotation of complex carbohydrate structures in PDB files. BMC Bioinformatics 5: 69","journal-title":"BMC Bioinformatics"},{"key":"BFEMBJ201593673_CR62","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1532\/IJH97.06117","volume":"84","author":"L Luzzatto","year":"2006","unstructured":"Luzzatto L, Gianfaldoni G (2006) Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria. Int J Hematol 84: 104\u2013112","journal-title":"Int J Hematol"},{"key":"BFEMBJ201593673_CR63","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1021\/bi4003452","volume":"52","author":"E Makou","year":"2013","unstructured":"Makou E, Herbert AP, Barlow PN (2013) Functional anatomy of complement factor H. Biochemistry 52: 3949\u20133962","journal-title":"Biochemistry"},{"key":"BFEMBJ201593673_CR64","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/anie.201108015","volume":"51","author":"A Marrero","year":"2012","unstructured":"Marrero A, Duquerroy S, Trapani S, Goulas T, Guevara T, Andersen GR, Navaza J, Sottrup\u2010Jensen L, Gomis\u2010Ruth FX (2012) The crystal structure of human alpha2\u2010macroglobulin reveals a unique molecular cage. Angew Chem Int Ed Engl 51: 3340\u20133344","journal-title":"Angew Chem Int Ed Engl"},{"key":"BFEMBJ201593673_CR65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molimm.2015.03.248","volume":"66","author":"R Martinez\u2010Barricarte","year":"2015","unstructured":"Martinez\u2010Barricarte R, Heurich M, Lopez\u2010Perrote A, Tortajada A, Pinto S, Lopez\u2010Trascasa M, Sanchez\u2010Corral P, Morgan BP, Llorca O, Harris CL, Rodriguez de Cordoba S (2015) The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome. Mol Immunol 66: 263\u2013273","journal-title":"Mol Immunol"},{"key":"BFEMBJ201593673_CR66","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1172\/JCI43343","volume":"120","author":"R Martinez\u2010Barricarte","year":"2010","unstructured":"Martinez\u2010Barricarte R, Heurich M, Valdes\u2010Canedo F, Vazquez\u2010Martul E, Torreira E, Montes T, Tortajada A, Pinto S, Lopez\u2010Trascasa M, Morgan BP, Llorca O, Harris CL, Rodriguez de Cordoba S (2010) Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation. J Clin Invest 120: 3702\u20133712","journal-title":"J Clin Invest"},{"key":"BFEMBJ201593673_CR67","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy AJ, Grosse\u2010Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658\u2013674","journal-title":"J Appl Crystallogr"},{"key":"BFEMBJ201593673_CR68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00239-004-2609-8","volume":"59","author":"CA McLure","year":"2004","unstructured":"McLure CA, Dawkins RL, Williamson JF, Davies RA, Berry J, Natalie LJ, Laird R, Gaudieri S (2004) Amino acid patterns within short consensus repeats define conserved duplicons shared by genes of the RCA complex. J Mol Evol 59: 143\u2013157","journal-title":"J Mol Evol"},{"key":"BFEMBJ201593673_CR69","first-page":"262","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Church SE, Fremeaux\u2010Bacchi V, Roumenina LT (2015a) Complement System Part I \u2010 Molecular Mechanisms of Activation and Regulation. Front Immunol 6: 262","journal-title":"Front Immunol"},{"key":"BFEMBJ201593673_CR70","first-page":"257","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Noe R, Halbwachs\u2010Mecarelli L, Fremeaux\u2010Bacchi V, Roumenina LT (2015b) Complement System Part II: Role in Immunity. Front Immunol 6: 257","journal-title":"Front Immunol"},{"key":"BFEMBJ201593673_CR71","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nsmb.2018","volume":"18","author":"HP Morgan","year":"2011","unstructured":"Morgan HP, Schmidt CQ, Guariento M, Blaum BS, Gillespie D, Herbert AP, Kavanagh D, Mertens HD, Svergun DI, Johansson CM, Uhrin D, Barlow PN, Hannan JP (2011) Structural basis for engagement by complement factor H of C3b on a self surface. Nat Struct Mol Biol 18: 463\u2013470","journal-title":"Nat Struct Mol Biol"},{"key":"BFEMBJ201593673_CR72","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.4049\/jimmunol.1500087","volume":"194","author":"S Mortensen","year":"2015","unstructured":"Mortensen S, Kidmose RT, Petersen SV, Szilagyi A, Prohaszka Z, Andersen GR (2015) Structural Basis for the Function of Complement Component C4 within the Classical and Lectin Pathways of Complement. J Immunol 194: 5488\u20135496","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR73","first-page":"485","volume":"123","author":"A Nicholson\u2010Weller","year":"1994","unstructured":"Nicholson\u2010Weller A, Wang CE (1994) Structure and function of decay accelerating factor CD55. J Lab Clin Med 123: 485\u2013491","journal-title":"J Lab Clin Med"},{"key":"BFEMBJ201593673_CR74","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.0105-2896.2004.00118.x","volume":"198","author":"M Nonaka","year":"2004","unstructured":"Nonaka M, Yoshizaki F (2004) Primitive complement system of invertebrates. Immunol Rev 198: 203\u2013215","journal-title":"Immunol Rev"},{"key":"BFEMBJ201593673_CR75","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5: 1844\u20131859","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFEMBJ201593673_CR76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molimm.2014.06.004","volume":"61","author":"H Ojha","year":"2014","unstructured":"Ojha H, Panwar HS, Gorham RD Jr, Morikis D, Sahu A (2014) Viral regulators of complement activation: structure, function and evolution. Mol Immunol 61: 89\u201399","journal-title":"Mol Immunol"},{"key":"BFEMBJ201593673_CR77","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1074\/jbc.274.8.5120","volume":"274","author":"AE Oran","year":"1999","unstructured":"Oran AE, Isenman DE (1999) Identification of residues within the 727\u2013767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35). J Biol Chem 274: 5120\u20135130","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR78","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1074\/jbc.M113.520346","volume":"289","author":"HJ Park","year":"2014","unstructured":"Park HJ, Guariento M, Maciejewski M, Hauhart R, Tham WH, Cowman AF, Schmidt CQ, Mertens HD, Liszewski MK, Hourcade DE, Barlow PN, Atkinson JP (2014) Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor. J Biol Chem 289: 450\u2013463","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR79","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1074\/jbc.M110.211839","volume":"286","author":"IC Pechtl","year":"2011","unstructured":"Pechtl IC, Kavanagh D, McIntosh N, Harris CL, Barlow PN (2011) Disease\u2010associated N\u2010terminal complement factor H mutations perturb cofactor and decay\u2010accelerating activities. J Biol Chem 286: 11082\u201311090","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR80","doi-asserted-by":"crossref","first-page":"e1001122","DOI":"10.1371\/journal.ppat.1001122","volume":"6","author":"BD Persson","year":"2010","unstructured":"Persson BD, Schmitz NB, Santiago C, Zocher G, Larvie M, Scheu U, Casasnovas JM, Stehle T (2010) Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens. PLoS Pathog 6: e1001122","journal-title":"PLoS Pathog"},{"key":"BFEMBJ201593673_CR81","doi-asserted-by":"crossref","first-page":"13419","DOI":"10.1073\/pnas.212519299","volume":"99","author":"PJ Reeves","year":"2002","unstructured":"Reeves PJ, Callewaert N, Contreras R, Khorana HG (2002) Structure and function in rhodopsin: high\u2010level expression of rhodopsin with restricted and homogeneous N\u2010glycosylation by a tetracycline\u2010inducible N\u2010acetylglucosaminyltransferase I\u2010negative HEK293S stable mammalian cell line. Proc Natl Acad Sci USA 99: 13419\u201313424","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201593673_CR82","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","volume":"100","author":"A Richards","year":"2003","unstructured":"Richards A, Kemp EJ, Liszewski MK, Goodship JA, Lampe AK, Decorte R, Muslumanoglu MH, Kavukcu S, Filler G, Pirson Y, Wen LS, Atkinson JP, Goodship TH (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci USA 100: 12966\u201312971","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201593673_CR83","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11: 785\u2013797","journal-title":"Nat Immunol"},{"key":"BFEMBJ201593673_CR84","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.4049\/jimmunol.1203487","volume":"190","author":"D Ricklin","year":"2013","unstructured":"Ricklin D, Lambris JD (2013a) Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol 190: 3831\u20133838","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR85","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.4049\/jimmunol.1203200","volume":"190","author":"D Ricklin","year":"2013","unstructured":"Ricklin D, Lambris JD (2013b) Complement in immune and inflammatory disorders: therapeutic interventions. J Immunol 190: 3839\u20133847","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR86","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.4049\/jimmunol.169.10.5405","volume":"169","author":"RC Riley","year":"2002","unstructured":"Riley RC, Tannenbaum PL, Abbott DH, Atkinson JP (2002) Cutting edge: inhibiting measles virus infection but promoting reproduction: an explanation for splicing and tissue\u2010specific expression of CD46. J Immunol 169: 5405\u20135409","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR87","doi-asserted-by":"crossref","first-page":"e00146","DOI":"10.1042\/BSR20140117","volume":"34","author":"E Rodriguez","year":"2014","unstructured":"Rodriguez E, Rallapalli PM, Osborne AJ, Perkins SJ (2014) New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3. Biosci Rep 34: e00146","journal-title":"Biosci Rep"},{"key":"BFEMBJ201593673_CR88","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ni.1756","volume":"10","author":"SH Rooijakkers","year":"2009","unstructured":"Rooijakkers SH, Wu J, Ruyken M, van Domselaar R, Planken KL, Tzekou A, Ricklin D, Lambris JD, Janssen BJ, van Strijp JA, Gros P (2009) Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat Immunol 10: 721\u2013727","journal-title":"Nat Immunol"},{"key":"BFEMBJ201593673_CR89","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1073\/pnas.112220499","volume":"99","author":"AM Rosengard","year":"2002","unstructured":"Rosengard AM, Liu Y, Nie Z, Jimenez R (2002) Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc Natl Acad Sci USA 99: 8808\u20138813","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201593673_CR90","doi-asserted-by":"crossref","first-page":"12839","DOI":"10.1073\/pnas.1102167108","volume":"108","author":"P Roversi","year":"2011","unstructured":"Roversi P, Johnson S, Caesar JJ, McLean F, Leath KJ, Tsiftsoglou SA, Morgan BP, Harris CL, Sim RB, Lea SM (2011) Structural basis for complement factor I control and its disease\u2010associated sequence polymorphisms. Proc Natl Acad Sci USA 108: 12839\u201312844","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201593673_CR91","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.4049\/jimmunol.1203548","volume":"190","author":"CQ Schmidt","year":"2013","unstructured":"Schmidt CQ, Bai H, Lin Z, Risitano AM, Barlow PN, Ricklin D, Lambris JD (2013) Rational engineering of a minimized immune inhibitor with unique triple\u2010targeting properties. J Immunol 190: 5712\u20135721","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR92","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.molimm.2015.03.006","volume":"67","author":"CQ Schmidt","year":"2015","unstructured":"Schmidt CQ, Kennedy AT, Tham WH (2015) More than just immune evasion: Hijacking complement by Plasmodium falciparum. Mol Immunol 67: 71\u201384","journal-title":"Mol Immunol"},{"key":"BFEMBJ201593673_CR93","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1182\/blood-2014-10-609073","volume":"125","author":"EC Schramm","year":"2015","unstructured":"Schramm EC, Roumenina LT, Rybkine T, Chauvet S, Vieira\u2010Martins P, Hue C, Maga T, Valoti E, Wilson V, Jokiranta S, Smith RJ, Noris M, Goodship T, Atkinson JP, Fremeaux\u2010Bacchi V (2015) Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome. Blood 125: 2359\u20132369","journal-title":"Blood"},{"key":"BFEMBJ201593673_CR94","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4049\/jimmunol.174.4.2143","volume":"174","author":"G Sfyroera","year":"2005","unstructured":"Sfyroera G, Katragadda M, Morikis D, Isaacs SN, Lambris JD (2005) Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins. J Immunol 174: 2143\u20132151","journal-title":"J Immunol"},{"key":"BFEMBJ201593673_CR95","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.it.2008.11.003","volume":"30","author":"AP Sjoberg","year":"2009","unstructured":"Sjoberg AP, Trouw LA, Blom AM (2009) Complement activation and inhibition: a delicate balance. Trends Immunol 30: 83\u201390","journal-title":"Trends Immunol"},{"key":"BFEMBJ201593673_CR96","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0092-8674(02)00672-4","volume":"108","author":"BO Smith","year":"2002","unstructured":"Smith BO, Mallin RL, Krych\u2010Goldberg M, Wang X, Hauhart RE, Bromek K, Uhrin D, Atkinson JP, Barlow PN (2002) Structure of the C3b binding site\u00a0of CR1 (CD35), the immune adherence receptor. Cell 108: 769\u2013780","journal-title":"Cell"},{"key":"BFEMBJ201593673_CR97","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.gene.6364150","volume":"6","author":"BN Thomas","year":"2005","unstructured":"Thomas BN, Donvito B, Cockburn I, Fandeur T, Rowe JA, Cohen JH, Moulds JM (2005) A complement receptor\u20101 polymorphism with high frequency in malaria endemic regions of Asia but not Africa. Genes Immun 6: 31\u201336","journal-title":"Genes Immun"},{"key":"BFEMBJ201593673_CR98","first-page":"50548","volume":"78","author":"M Till","year":"2013","unstructured":"Till M, Robson A, Byrne MJ, Nair AV, Kolek SA, Shaw Stewart PD, Race PR (2013) Improving the success rate of protein crystallization by random microseed matrix screening. J Vis Exp 78: 50548","journal-title":"J Vis Exp"},{"key":"BFEMBJ201593673_CR99","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1093\/hmg\/ddp289","volume":"18","author":"A Tortajada","year":"2009","unstructured":"Tortajada A, Montes T, Martinez\u2010Barricarte R, Morgan BP, Harris CL, de Cordoba SR (2009) The disease\u2010protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity. Hum Mol Genet 18: 3452\u20133461","journal-title":"Hum Mol Genet"},{"key":"BFEMBJ201593673_CR100","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1073\/pnas.0730844100","volume":"100","author":"S Uhrinova","year":"2003","unstructured":"Uhrinova S, Lin F, Ball G, Bromek K, Uhrin D, Medof ME, Barlow PN (2003) Solution structure of a functionally active fragment of decay\u2010accelerating factor. Proc Natl Acad Sci USA 100: 4718\u20134723","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201593673_CR101","first-page":"64","volume":"103","author":"HF Weisman","year":"1990","unstructured":"Weisman HF, Bartow T, Leppo MK, Boyle MP, Marsh HC Jr, Carson GR, Roux KH, Weisfeldt ML, Fearon DT (1990) Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardium. Trans Assoc Am Physicians 103: 64\u201372","journal-title":"Trans Assoc Am Physicians"},{"key":"BFEMBJ201593673_CR102","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature05263","volume":"444","author":"C Wiesmann","year":"2006","unstructured":"Wiesmann C, Katschke KJ, Yin J, Helmy KY, Steffek M, Fairbrother WJ, McCallum SA, Embuscado L, DeForge L, Hass PE, van Lookeren Campagne M (2006) Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature 444: 217\u2013220","journal-title":"Nature"},{"key":"BFEMBJ201593673_CR103","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1074\/jbc.M212561200","volume":"278","author":"P Williams","year":"2003","unstructured":"Williams P, Chaudhry Y, Goodfellow IG, Billington J, Powell R, Spiller OB, Evans DJ, Lea S (2003) Mapping CD55 function. The structure of two\u00a0pathogen\u2010binding domains at 1.7 A. J Biol Chem 278: 10691\u201310696","journal-title":"J Biol Chem"},{"key":"BFEMBJ201593673_CR104","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ni.1755","volume":"10","author":"J Wu","year":"2009","unstructured":"Wu J, Wu YQ, Ricklin D, Janssen BJ, Lambris JD, Gros P (2009) Structure of complement fragment C3b\u2010factor H and implications for host protection by complement regulators. Nat Immunol 10: 728\u2013733","journal-title":"Nat Immunol"},{"key":"BFEMBJ201593673_CR105","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1128\/JVI.01935-07","volume":"82","author":"VN Yadav","year":"2008","unstructured":"Yadav VN, Pyaram K, Mullick J, Sahu A (2008) Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation. J Virol 82: 3283\u20133294","journal-title":"J Virol"},{"key":"BFEMBJ201593673_CR106","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.molimm.2013.05.222","volume":"56","author":"PF Zipfel","year":"2013","unstructured":"Zipfel PF, Hallstrom T, Riesbeck K (2013) Human complement control and complement evasion by pathogenic microbes\u2013tipping the balance. Mol Immunol 56: 152\u2013160","journal-title":"Mol Immunol"},{"key":"BFEMBJ201593673_CR107","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel PF, Skerka C (2009) Complement regulators and inhibitory proteins. Nat Rev Immunol 9: 729\u2013740","journal-title":"Nat Rev Immunol"}],"container-title":["The EMBO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embj.201593673.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/embj.201593673","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/embj.201593673\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/embj.201593673","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.embopress.org\/doi\/full\/10.15252\/embj.201593673","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/embj.201593673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embj.201593673.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:35:20Z","timestamp":1779305720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/embj.201593673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,24]]},"references-count":109,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,5,17]]}},"alternative-id":["BFEMBJ201593673"],"URL":"https:\/\/doi.org\/10.15252\/embj.201593673","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726236801.793522569","asserted-by":"object"}]},"ISSN":["0261-4189","1460-2075"],"issn-type":[{"value":"0261-4189","type":"print"},{"value":"1460-2075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,24]]},"assertion":[{"value":"11 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}